Modern Medicine Feature Articles

Shire utilizing biotech approach to meet unmet ophthalmic needsShire, which built its experience in biotech agents, is taking a biotech approach to meeting unmet needs in both the anterior and poster segments of ophthalmology.
Artificial intelligence will bring ‘reality’ to glaucoma diagnosisRobert Chang, MD, outlines how artificial intelligence might work in glaucoma.
New world order of glaucoma presenting strong challengesChanges in both technology and the healthcare policy are presenting new challenges for glaucoma specialists. As the demand for eye care surges, ophthalmologists are struggling to keep up–despite the availability of better tools for diagnosis and treatment.
Micropulse probe transforms transscleral cyclophotocoagulationMicropulse transscleral cyclophotocoagulation with a diode laser is demonstrating promising efficacy with better safety and tolerability than traditional TSCPC.
How to evaluate the guidelines of antibiotic reactions in surgeryEye surgeons should use intracameral antibiotics only in select situations; they should avoid aminoglycosides, and they should not use vancomycin as prophylaxis. Michael Jumper, MD, offered this perspective as part of an overview of antibiotics used in intraocular surgery during the Glaucoma Symposium at the 2017 Glaucoma 360 meeting.
Novel drug delivery platforms: Filling a ‘GAP’ in glaucomaMedical therapy for glaucoma is not becoming obsolete, but it is evolving away from conventional topical administration.
Ubiquitous steroid use posing unwitting cause for glaucomaAll corticosteroids matter when it comes to the risk of an intraocular pressure (IOP) response, and that is an important point for ophthalmologists to remember because opportunities for corticosteroid exposure are growing.
Lifestyle modifications may help control glaucoma progressionYvonne Ou, MD, gives patients advice about physical activity, body positions to avoid, leafy green vegetables, caffeine, and blood pressure treatment–as suggestions to help patients control their glaucoma progression.
Home-monitoring devices offer better insight to figure out IOPL. Jay Katz, MD. outlined the benefits of home IOP monitoring. These devices will offer a wealth of information that should lead to increased understanding of glaucoma and better patient care.
End-stage glaucoma requires outside-of-the-box managementAlthough the aim of glaucoma management is to maintain visual function, the role of the ophthalmologist does not end once a patient has lost useful vision. Robert L. Stamper, MD, discussed care for patients with end-stage glaucoma.